Natixis Advisors
EXAS

Natixis Advisors’s Exact Sciences EXAS Stock Holding History

Natixis Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-68,818
Closed -$4.75M – 1596
2024
Q1 		$4.75M Sell
68,818
-6,888
-9% -$436K 0.01% 806
2023
Q4 		$5.6M Sell
75,706
-2,370
-3% -$155K 0.01% 720
2023
Q3 		$5.33M Sell
78,076
-1,114
-1% -$94.5K 0.02% 692
2023
Q2 		$7.44M Sell
79,190
-1,442
-2% -$112K 0.02% 607
2023
Q1 		$5.47M Buy
80,632
+5,185
+7% +$333K 0.02% 667
2022
Q4 		$3.73M Buy
75,447
+27,393
+57% +$1.12M 0.01% 756
2022
Q3 		$1.56M Buy
48,054
+9,137
+23% +$377K 0.01% 971
2022
Q2 		$1.53M Sell
38,917
-6,282
-14% -$336K 0.01% 986
2022
Q1 		$3.16M Sell
45,199
-4,465
-9% -$326K 0.01% 824
2021
Q4 		$3.87M Buy
49,664
+97
+0.2% +$8.56K 0.01% 753
2021
Q3 		$4.73M Buy
49,567
+10,546
+27% +$1.11M 0.02% 654
2021
Q2 		$4.85M Buy
39,021
+19
+0% +$2.27K 0.02% 645
2021
Q1 		$5.14M Sell
39,002
-1,818
-4% -$249K 0.03% 587
2020
Q4 		$5.41M Buy
40,820
+12,747
+45% +$1.54M 0.03% 524
2020
Q3 		$2.86M Sell
28,073
-1,920
-6% -$166K 0.02% 698
2020
Q2 		$2.61M Buy
29,993
+5,152
+21% +$412K 0.02% 725
2020
Q1 		$1.44M Buy
24,841
+3,857
+18% +$313K 0.01% 817
2019
Q4 		$1.94M Buy
20,984
+2,606
+14% +$229K 0.01% 809
2019
Q3 		$1.66M Sell
18,378
-145
-0.8% -$16.5K 0.01% 819
2019
Q2 		$2.19M Buy
18,523
+197
+1% +$19.9K 0.02% 749
2019
Q1 		$1.59M Buy
18,326
+1,231
+7% +$105K 0.01% 824
2018
Q4 		$1.08M Buy
17,095
+5,514
+48% +$378K 0.01% 884
2018
Q3 		$914K Buy
+11,581
New +$755K 0.01% 970

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Natixis Advisors's EXAS Position: Q2 2024 in Review

Natixis Advisors sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 68,818 shares — an estimated $4.75M sold.

Natixis Advisors first reported a position in EXAS in Q3 2018 and held it in 23 quarters. The position peaked at $7.44M in Q2 2023. 542 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Natixis Advisors reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Natixis Advisors sold 68,818 Exact Sciences shares in Q2 2024, an estimated $4.75M.
  • Natixis Advisors first reported a position in Exact Sciences in Q3 2018 and held it in 23 quarters.
  • Natixis Advisors's Exact Sciences position peaked at $7.44M in Q2 2023.
  • 542 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Natixis Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.